ALEXIS MULLIKIN: Open Payments
NPI 1811589013 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,816 in 76 payments from 11 companies in 2025. Trend: 2023 $1,263 · 2024 $2,379 · 2025 $1,816
Food & beverage: $1,816
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $925 |
| Amgen Inc. | 12 | $199 |
| Janssen Biotech, Inc. | 1 | $145 |
| AstraZeneca Pharmaceuticals LP | 6 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| GENZYME CORPORATION | 4 | $82 |
| UCB, Inc. | 1 | $79 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| PFIZER INC. | 2 | $30 |
Products named: RINVOQ, SKYRIZI, TREMFYA, SAPHNELO, OTEZLA, COSENTYX, KEVZARA, Bimzelx.
Industry payments across OH — which companies pay providers there.
